Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
Blood Cancer J
.
2023 Apr 10;13(1):50.
doi: 10.1038/s41408-023-00824-8.
Authors
Ahmad Alcheikh
#
1
,
Griffith B Perkins
#
2
3
4
,
Phillippa A Pucar
3
5
,
Amelia Cecchin
3
,
Cheng Sheng Chai
4
,
Matthew Tunbridge
2
,
Anouschka Akerman
6
,
Anupriya Aggarwal
6
,
Vanessa Milogiannakis
6
,
Stuart Turville
6
,
Sharon Allen
7
,
Pravin Hissaria
2
3
5
,
Tatjana Banovic
3
5
,
P Toby Coates
2
4
,
David M Ross
7
4
8
9
Affiliations
1
Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia.
[email protected]
.
2
Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
3
Immunology Directorate, SA Pathology, Adelaide, Australia.
4
Adelaide Medical School, University of Adelaide, Adelaide, Australia.
5
Department of Immunology, Royal Adelaide Hospital, Adelaide, Australia.
6
Kirby Institute, University of New South Wales, Sydney, Australia.
7
Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia.
8
Haematology Directorate, SA Pathology, Adelaide, Australia.
9
Department of Haematology, Flinders University and Medical Centre, Adelaide, Australia.
#
Contributed equally.
PMID:
37032391
PMCID:
PMC10083173
DOI:
10.1038/s41408-023-00824-8
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / prevention & control
Humans
Immunity, Cellular
Primary Myelofibrosis* / genetics
SARS-CoV-2
Vaccination